Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease

Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease

Background and Aims: Non-invasive fibrosis staging is essential in metabolic associated fatty liver disease (MAFLD). Transient elastography (TE) is a well-established method for liver fibrosis assessment. We have previously shown that the macrophage marker sCD163 is an independent predictor for fibr...

Full description

Bibliographic Details
Main Authors: Konstantin Kazankov, Chiara Rosso, Ramy Younes, Angelo Armandi, Hannes Hagström, Holger Jon Møller, Per Stål, Elisabetta Bugianesi, Henning Grønbæk
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Medicine
Subjects:
macrophages
cirrhosis
biomarkers
NAFLD
Fibroscan
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2020.616212/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2020.616212/full

Similar Items